Cargando…
IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014366/ http://dx.doi.org/10.1016/j.diabres.2023.110543 |
| _version_ | 1784906978692169728 |
|---|---|
| author | Kristófl, R. Bodegard, J. Ritsinger, V. Thuresson, M. Nathanson, D. Nyström, T. Norhammar, A. Eriksson, J.W. |
| author_facet | Kristófl, R. Bodegard, J. Ritsinger, V. Thuresson, M. Nathanson, D. Nyström, T. Norhammar, A. Eriksson, J.W. |
| author_sort | Kristófl, R. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10014366 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier B.V. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-100143662023-03-15 IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden Kristófl, R. Bodegard, J. Ritsinger, V. Thuresson, M. Nathanson, D. Nyström, T. Norhammar, A. Eriksson, J.W. Diabetes Res Clin Pract Other Elsevier B.V. 2023-03 2023-03-15 /pmc/articles/PMC10014366/ http://dx.doi.org/10.1016/j.diabres.2023.110543 Text en Copyright © 2023 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Other Kristófl, R. Bodegard, J. Ritsinger, V. Thuresson, M. Nathanson, D. Nyström, T. Norhammar, A. Eriksson, J.W. IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden |
| title | IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden |
| title_full | IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden |
| title_fullStr | IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden |
| title_full_unstemmed | IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden |
| title_short | IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden |
| title_sort | idf2022-0622 mortality and cardiorenal disease in type 1 and type 2 diabetes after covid-19 and influenza hospitalization in sweden |
| topic | Other |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10014366/ http://dx.doi.org/10.1016/j.diabres.2023.110543 |
| work_keys_str_mv | AT kristoflr idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT bodegardj idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT ritsingerv idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT thuressonm idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT nathansond idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT nystromt idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT norhammara idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden AT erikssonjw idf20220622mortalityandcardiorenaldiseaseintype1andtype2diabetesaftercovid19andinfluenzahospitalizationinsweden |